BioSensor Laboratories (“BSL”) is a Korean biotechnology company that has created a patented Tissue X™ technology, a non-invasive transdermal drug delivery technology system (“TDDS”) that conveniently delivers the benefits of iontophoresis treatments to your skin, without the hassle of external devices. Tissue X™ was made possible through multi-disciplinary collaboration with researchers at Seoul National University and Samsung Hospital, two of the top research organizations in Asia. FRANZ is BSL’s first skincare brand utilizing this revolutionary and academically proven Tissue X™ technology.
Using Tissue X™, FRANZ Microcurrent Dual Masks naturally generate microcurrents without any devices, equipment or external battery power source and is academically and clinically proven to deliver macromolecule compounds such as hyaluronic acid, peptides, ceramides and vitamins into deeper layers of the skin compared to traditional sheet masks.
FRANZ is one of the fastest growing cosmeceutical brands in Korea, the hub of innovative skincare solutions. It has also recently launched in global markets including US, Germany, Japan and China. In the US market, the brand is making strong headway in the professional beauty clinics and aesthetician markets.